Is Vancomycin-only Prophylaxis for Patients With Penicillin Allergy Associated With Increased Risk of Infection After Arthroplasty? View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-07

AUTHORS

Timothy L. Tan, Bryan D. Springer, John A. Ruder, Michael R. Ruffolo, Antonia F. Chen

ABSTRACT

BACKGROUND: Preoperative antibiotic prophylaxis remains one of the most important strategies for prevention of postoperative infection. In patients with penicillin allergy, alternative medications such as vancomycin are often used despite reduced antimicrobial coverage and recent literature questioning the efficacy of vancomycin monotherapy. QUESTIONS/PURPOSES: (1) Are patients who receive vancomycin alone for penicillin allergy at greater odds of developing surgical site infection (SSI) as compared with patients who receive cefazolin for prophylaxis before total joint arthroplasty (TJA) without a patient-reported allergy? (2) What organism profile is associated with vancomycin monotherapy? METHODS: We performed a retrospective study of 10,391 primary TJAs performed between 2005 and 2014 at two institutions with a minimum of 1-year followup. Patients reporting penicillin or cephalosporin allergy were electronically queried from the anesthesia note. The odds of deep SSI and causative organisms were compared using multivariate analysis between β-lactam-allergic patients receiving vancomycin and nonallergic patients receiving cefazolin. RESULTS: After controlling for potential confounders, including comorbidities, we found that vancomycin alone did not affect the odds of deep SSI development (adjusted odds ratio [OR], 0.98; 95% confidence interval [CI], 0.67-1.43; p = 0.907). Although the overall odds of deep SSI were not different for patients receiving vancomycin versus cefazolin, we found that vancomycin was associated with a reduced risk of infection with Gram-positive organisms (adjusted OR, 0.25 [CI, 0.10-0.62]; p = 0.003) and antibiotic-resistant organisms (adjusted OR, 0.10 [CI, 0.01-0.88]; p = 0.038). Vancomycin also demonstrated an increased risk of Gram-negative infection in bivariate analysis (OR, 2.42 [CI, 1.01-5.82]; p = 0.049) compared to cefazolin. CONCLUSIONS: With the numbers available, vancomycin alone during elective primary TJA does not seem to result in a higher rate of subsequent deep SSI. However, patients who received vancomycin alone demonstrated reduced odds of Gram-positive organisms and methicillin-resistant Staphylococcus aureus. Vancomycin monotherapy can be used without increasing the risk of deep SSI; however, it should only be used in patients who require vancomycin, eg, anaphylactic reactions to penicillin resulting from the potential for the emergence of organism resistance and nephrotoxicity. Future studies are needed that use registry and large database studies to refute or confirm the preliminary findings of this study and determine if vancomycin monotherapy influences the risk of periprosthetic joint infection. LEVEL OF EVIDENCE: Level III, therapeutic study. More... »

PAGES

1601-1606

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11999-015-4672-4

DOI

http://dx.doi.org/10.1007/s11999-015-4672-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1025756342

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26689584


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Bacterial Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibiotic Prophylaxis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arthroplasty, Replacement", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cefazolin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cross Infection", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Hypersensitivity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Logistic Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multivariate Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "North Carolina", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Odds Ratio", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Penicillins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Philadelphia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protective Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Surgical Wound Infection", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vancomycin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Thomas Jefferson University", 
          "id": "https://www.grid.ac/institutes/grid.265008.9", 
          "name": [
            "Rothman Institute at Thomas Jefferson University, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tan", 
        "givenName": "Timothy L.", 
        "id": "sg:person.01103301641.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103301641.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "OrthoCarolina", 
          "id": "https://www.grid.ac/institutes/grid.418446.b", 
          "name": [
            "OrthoCarolina, Charlotte, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Springer", 
        "givenName": "Bryan D.", 
        "id": "sg:person.01231726624.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231726624.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "OrthoCarolina", 
          "id": "https://www.grid.ac/institutes/grid.418446.b", 
          "name": [
            "OrthoCarolina, Charlotte, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ruder", 
        "givenName": "John A.", 
        "id": "sg:person.014077443323.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014077443323.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "OrthoCarolina", 
          "id": "https://www.grid.ac/institutes/grid.418446.b", 
          "name": [
            "OrthoCarolina, Charlotte, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ruffolo", 
        "givenName": "Michael R.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Thomas Jefferson University", 
          "id": "https://www.grid.ac/institutes/grid.265008.9", 
          "name": [
            "Rothman Institute at Thomas Jefferson University, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Antonia F.", 
        "id": "sg:person.0720501031.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720501031.10"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/jor.22549", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002096357"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.arth.2011.03.044", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011529868"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/605593", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012385427"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0021-9681(87)90171-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020988115"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11999-012-2255-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024095772", 
          "https://doi.org/10.1007/s11999-012-2255-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1007/s11999-012-2255-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024095772"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1007/s11999-012-2255-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024095772"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.arth.2012.03.040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025869441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1067/mtc.2002.119698", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028764631"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1081-1206(10)62466-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030993384"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.arth.2010.01.105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031521144"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjsurg.2005.01.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042842159"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.162.7.822", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049908466"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjmed.2005.10.052", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050626598"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1398-9995.1994.tb00809.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051534928"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2106/jbjs.m.00663", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068903536"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2106/jbjs.m.00663", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068903536"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2106/jbjs.m.00663", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068903536"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078990362", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-07", 
    "datePublishedReg": "2016-07-01", 
    "description": "BACKGROUND: Preoperative antibiotic prophylaxis remains one of the most important strategies for prevention of postoperative infection. In patients with penicillin allergy, alternative medications such as vancomycin are often used despite reduced antimicrobial coverage and recent literature questioning the efficacy of vancomycin monotherapy.\nQUESTIONS/PURPOSES: (1) Are patients who receive vancomycin alone for penicillin allergy at greater odds of developing surgical site infection (SSI) as compared with patients who receive cefazolin for prophylaxis before total joint arthroplasty (TJA) without a patient-reported allergy? (2) What organism profile is associated with vancomycin monotherapy?\nMETHODS: We performed a retrospective study of 10,391 primary TJAs performed between 2005 and 2014 at two institutions with a minimum of 1-year followup. Patients reporting penicillin or cephalosporin allergy were electronically queried from the anesthesia note. The odds of deep SSI and causative organisms were compared using multivariate analysis between \u03b2-lactam-allergic patients receiving vancomycin and nonallergic patients receiving cefazolin.\nRESULTS: After controlling for potential confounders, including comorbidities, we found that vancomycin alone did not affect the odds of deep SSI development (adjusted odds ratio [OR], 0.98; 95% confidence interval [CI], 0.67-1.43; p = 0.907). Although the overall odds of deep SSI were not different for patients receiving vancomycin versus cefazolin, we found that vancomycin was associated with a reduced risk of infection with Gram-positive organisms (adjusted OR, 0.25 [CI, 0.10-0.62]; p = 0.003) and antibiotic-resistant organisms (adjusted OR, 0.10 [CI, 0.01-0.88]; p = 0.038).\u00a0Vancomycin also demonstrated an increased risk of Gram-negative infection in bivariate analysis (OR, 2.42 [CI, 1.01-5.82]; p\u00a0=\u00a00.049) compared to cefazolin.\nCONCLUSIONS: With the numbers available, vancomycin alone during elective primary TJA does not seem to result in a higher rate of subsequent deep SSI. However, patients who received vancomycin alone demonstrated reduced odds of Gram-positive organisms and methicillin-resistant Staphylococcus aureus. Vancomycin monotherapy can be used without increasing the risk of deep SSI; however, it should only be used in patients who require vancomycin, eg, anaphylactic reactions to penicillin resulting from the potential for the emergence of organism resistance and nephrotoxicity. Future studies are needed that use registry and large database studies to refute or confirm the preliminary findings of this study and determine if vancomycin monotherapy influences the risk of periprosthetic joint infection.\nLEVEL OF EVIDENCE: Level III, therapeutic study.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11999-015-4672-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1007212", 
        "issn": [
          "0009-921X", 
          "1528-1132"
        ], 
        "name": "Clinical Orthopaedics and Related Research\u00ae", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "474"
      }
    ], 
    "name": "Is Vancomycin-only Prophylaxis for Patients With Penicillin Allergy Associated With Increased Risk of Infection After Arthroplasty?", 
    "pagination": "1601-1606", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "7ab4c93f2dc0c6333a71294ce142b3b289c0dd2b68f5b1742e320262efe80775"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26689584"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0075674"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11999-015-4672-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1025756342"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11999-015-4672-4", 
      "https://app.dimensions.ai/details/publication/pub.1025756342"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000347_0000000347/records_89824_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs11999-015-4672-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11999-015-4672-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11999-015-4672-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11999-015-4672-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11999-015-4672-4'


 

This table displays all metadata directly associated to this object as RDF triples.

251 TRIPLES      21 PREDICATES      71 URIs      47 LITERALS      35 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11999-015-4672-4 schema:about N0a8fbd00c469452b934cacaaade4b457
2 N0c7b8562af11494b90ede32617228352
3 N0d6dd02434e247268122f69f14347f6b
4 N14be3eb9b3ca48c6b1fd0998efdc7961
5 N30abd3fb32b9418c89331d54e2ead6b9
6 N4211f47d21f547c4831871e66be23bba
7 N42b7d270d8ce49e5ae9f3c65e5dc7f07
8 N500687bdf7f14cfa9fab35f15ac026a2
9 N6094c7fb80964886beb716351cc5ef9a
10 N69190e7c5e204bc2a43deef54fe5c64e
11 N74eab200d1d6421d844ce81f8f3927c8
12 N78be589be0a143f48f9ec3b04ea1fc8c
13 N800a486e3e3641cb97846b6208c16a11
14 N89343b41a1164f7594c27e36c15e5c93
15 N8b9e6c25b8b445449bc95742dbdbbcc3
16 Na18b81ac88084fa4a02dbf566d54a891
17 Naca0f7febcf54a8bae03edd70a6326aa
18 Nb1848c90220c4f5ab2625edd1096bc9a
19 Nb252f97bbb814d5b8c89c1f7dc15d892
20 Nb5fe177ce1f44b0ea0da86a9371e9297
21 Nbc2cabee3f364fb191df25286341f42a
22 Nbcbe7f0076184b01bc4e136dbf89a638
23 Nbf3926c0ff2843cca0141bc19d31879e
24 Ncc72071f1f74480eb957806b45522330
25 Nccea91c1a1f14f30b71de7def98f4cac
26 Nd69a9a72bb5b4995adae89f14cc92e2b
27 anzsrc-for:11
28 anzsrc-for:1103
29 schema:author N617b756af93c4f239f6baa19a1b96a2d
30 schema:citation sg:pub.10.1007/s11999-012-2255-1
31 https://app.dimensions.ai/details/publication/pub.1078990362
32 https://doi.org/10.1001/archinte.162.7.822
33 https://doi.org/10.1002/jor.22549
34 https://doi.org/10.1007/s11999-012-2255-1
35 https://doi.org/10.1016/0021-9681(87)90171-8
36 https://doi.org/10.1016/j.amjmed.2005.10.052
37 https://doi.org/10.1016/j.amjsurg.2005.01.015
38 https://doi.org/10.1016/j.arth.2010.01.105
39 https://doi.org/10.1016/j.arth.2011.03.044
40 https://doi.org/10.1016/j.arth.2012.03.040
41 https://doi.org/10.1016/s1081-1206(10)62466-0
42 https://doi.org/10.1067/mtc.2002.119698
43 https://doi.org/10.1086/605593
44 https://doi.org/10.1111/j.1398-9995.1994.tb00809.x
45 https://doi.org/10.2106/jbjs.m.00663
46 schema:datePublished 2016-07
47 schema:datePublishedReg 2016-07-01
48 schema:description BACKGROUND: Preoperative antibiotic prophylaxis remains one of the most important strategies for prevention of postoperative infection. In patients with penicillin allergy, alternative medications such as vancomycin are often used despite reduced antimicrobial coverage and recent literature questioning the efficacy of vancomycin monotherapy. QUESTIONS/PURPOSES: (1) Are patients who receive vancomycin alone for penicillin allergy at greater odds of developing surgical site infection (SSI) as compared with patients who receive cefazolin for prophylaxis before total joint arthroplasty (TJA) without a patient-reported allergy? (2) What organism profile is associated with vancomycin monotherapy? METHODS: We performed a retrospective study of 10,391 primary TJAs performed between 2005 and 2014 at two institutions with a minimum of 1-year followup. Patients reporting penicillin or cephalosporin allergy were electronically queried from the anesthesia note. The odds of deep SSI and causative organisms were compared using multivariate analysis between β-lactam-allergic patients receiving vancomycin and nonallergic patients receiving cefazolin. RESULTS: After controlling for potential confounders, including comorbidities, we found that vancomycin alone did not affect the odds of deep SSI development (adjusted odds ratio [OR], 0.98; 95% confidence interval [CI], 0.67-1.43; p = 0.907). Although the overall odds of deep SSI were not different for patients receiving vancomycin versus cefazolin, we found that vancomycin was associated with a reduced risk of infection with Gram-positive organisms (adjusted OR, 0.25 [CI, 0.10-0.62]; p = 0.003) and antibiotic-resistant organisms (adjusted OR, 0.10 [CI, 0.01-0.88]; p = 0.038). Vancomycin also demonstrated an increased risk of Gram-negative infection in bivariate analysis (OR, 2.42 [CI, 1.01-5.82]; p = 0.049) compared to cefazolin. CONCLUSIONS: With the numbers available, vancomycin alone during elective primary TJA does not seem to result in a higher rate of subsequent deep SSI. However, patients who received vancomycin alone demonstrated reduced odds of Gram-positive organisms and methicillin-resistant Staphylococcus aureus. Vancomycin monotherapy can be used without increasing the risk of deep SSI; however, it should only be used in patients who require vancomycin, eg, anaphylactic reactions to penicillin resulting from the potential for the emergence of organism resistance and nephrotoxicity. Future studies are needed that use registry and large database studies to refute or confirm the preliminary findings of this study and determine if vancomycin monotherapy influences the risk of periprosthetic joint infection. LEVEL OF EVIDENCE: Level III, therapeutic study.
49 schema:genre research_article
50 schema:inLanguage en
51 schema:isAccessibleForFree true
52 schema:isPartOf N501e098494974c0b80583800032f582c
53 Nbf75f174896c4526a3ca26f0fb75f7ba
54 sg:journal.1007212
55 schema:name Is Vancomycin-only Prophylaxis for Patients With Penicillin Allergy Associated With Increased Risk of Infection After Arthroplasty?
56 schema:pagination 1601-1606
57 schema:productId N13210c90c912476ca12424b5d91d58b1
58 N321ee5dcb7724955a16d0f0b3d501d33
59 N6f44da74f35f4fe88b8a2619b18f38b7
60 Nab52e6d8b9be43f09ac79d8da428cb39
61 Nad8fe182214b4516a400bd96516e7732
62 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025756342
63 https://doi.org/10.1007/s11999-015-4672-4
64 schema:sdDatePublished 2019-04-11T10:03
65 schema:sdLicense https://scigraph.springernature.com/explorer/license/
66 schema:sdPublisher Ne9798802eb774d518ea7a42be1a2de9f
67 schema:url https://link.springer.com/10.1007%2Fs11999-015-4672-4
68 sgo:license sg:explorer/license/
69 sgo:sdDataset articles
70 rdf:type schema:ScholarlyArticle
71 N0a8fbd00c469452b934cacaaade4b457 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Male
73 rdf:type schema:DefinedTerm
74 N0c7b8562af11494b90ede32617228352 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Middle Aged
76 rdf:type schema:DefinedTerm
77 N0d6dd02434e247268122f69f14347f6b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Protective Factors
79 rdf:type schema:DefinedTerm
80 N13167466132749109ea7ac4d57a62130 rdf:first sg:person.0720501031.10
81 rdf:rest rdf:nil
82 N13210c90c912476ca12424b5d91d58b1 schema:name nlm_unique_id
83 schema:value 0075674
84 rdf:type schema:PropertyValue
85 N14be3eb9b3ca48c6b1fd0998efdc7961 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Retrospective Studies
87 rdf:type schema:DefinedTerm
88 N30abd3fb32b9418c89331d54e2ead6b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Surgical Wound Infection
90 rdf:type schema:DefinedTerm
91 N321ee5dcb7724955a16d0f0b3d501d33 schema:name readcube_id
92 schema:value 7ab4c93f2dc0c6333a71294ce142b3b289c0dd2b68f5b1742e320262efe80775
93 rdf:type schema:PropertyValue
94 N4211f47d21f547c4831871e66be23bba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Arthroplasty, Replacement
96 rdf:type schema:DefinedTerm
97 N42b7d270d8ce49e5ae9f3c65e5dc7f07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Drug Hypersensitivity
99 rdf:type schema:DefinedTerm
100 N4db8da0e8571477faeb7da595efad36c schema:affiliation https://www.grid.ac/institutes/grid.418446.b
101 schema:familyName Ruffolo
102 schema:givenName Michael R.
103 rdf:type schema:Person
104 N500687bdf7f14cfa9fab35f15ac026a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name North Carolina
106 rdf:type schema:DefinedTerm
107 N501e098494974c0b80583800032f582c schema:volumeNumber 474
108 rdf:type schema:PublicationVolume
109 N56b565c0b0024d109795ccce8257873b rdf:first N4db8da0e8571477faeb7da595efad36c
110 rdf:rest N13167466132749109ea7ac4d57a62130
111 N6094c7fb80964886beb716351cc5ef9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Philadelphia
113 rdf:type schema:DefinedTerm
114 N617b756af93c4f239f6baa19a1b96a2d rdf:first sg:person.01103301641.41
115 rdf:rest Nc80ed1252f324708a5e9571551dc0281
116 N69190e7c5e204bc2a43deef54fe5c64e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Penicillins
118 rdf:type schema:DefinedTerm
119 N6f44da74f35f4fe88b8a2619b18f38b7 schema:name pubmed_id
120 schema:value 26689584
121 rdf:type schema:PropertyValue
122 N73ac258473ab41ccba8342a26440a7b0 rdf:first sg:person.014077443323.12
123 rdf:rest N56b565c0b0024d109795ccce8257873b
124 N74eab200d1d6421d844ce81f8f3927c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Female
126 rdf:type schema:DefinedTerm
127 N78be589be0a143f48f9ec3b04ea1fc8c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Time Factors
129 rdf:type schema:DefinedTerm
130 N800a486e3e3641cb97846b6208c16a11 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Multivariate Analysis
132 rdf:type schema:DefinedTerm
133 N89343b41a1164f7594c27e36c15e5c93 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Odds Ratio
135 rdf:type schema:DefinedTerm
136 N8b9e6c25b8b445449bc95742dbdbbcc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Risk Assessment
138 rdf:type schema:DefinedTerm
139 Na18b81ac88084fa4a02dbf566d54a891 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Risk Factors
141 rdf:type schema:DefinedTerm
142 Nab52e6d8b9be43f09ac79d8da428cb39 schema:name dimensions_id
143 schema:value pub.1025756342
144 rdf:type schema:PropertyValue
145 Naca0f7febcf54a8bae03edd70a6326aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Aged
147 rdf:type schema:DefinedTerm
148 Nad8fe182214b4516a400bd96516e7732 schema:name doi
149 schema:value 10.1007/s11999-015-4672-4
150 rdf:type schema:PropertyValue
151 Nb1848c90220c4f5ab2625edd1096bc9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Antibiotic Prophylaxis
153 rdf:type schema:DefinedTerm
154 Nb252f97bbb814d5b8c89c1f7dc15d892 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Drug Administration Schedule
156 rdf:type schema:DefinedTerm
157 Nb5fe177ce1f44b0ea0da86a9371e9297 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Cross Infection
159 rdf:type schema:DefinedTerm
160 Nbc2cabee3f364fb191df25286341f42a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Humans
162 rdf:type schema:DefinedTerm
163 Nbcbe7f0076184b01bc4e136dbf89a638 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Vancomycin
165 rdf:type schema:DefinedTerm
166 Nbf3926c0ff2843cca0141bc19d31879e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Anti-Bacterial Agents
168 rdf:type schema:DefinedTerm
169 Nbf75f174896c4526a3ca26f0fb75f7ba schema:issueNumber 7
170 rdf:type schema:PublicationIssue
171 Nc80ed1252f324708a5e9571551dc0281 rdf:first sg:person.01231726624.06
172 rdf:rest N73ac258473ab41ccba8342a26440a7b0
173 Ncc72071f1f74480eb957806b45522330 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Cefazolin
175 rdf:type schema:DefinedTerm
176 Nccea91c1a1f14f30b71de7def98f4cac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Logistic Models
178 rdf:type schema:DefinedTerm
179 Nd69a9a72bb5b4995adae89f14cc92e2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Treatment Outcome
181 rdf:type schema:DefinedTerm
182 Ne9798802eb774d518ea7a42be1a2de9f schema:name Springer Nature - SN SciGraph project
183 rdf:type schema:Organization
184 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
185 schema:name Medical and Health Sciences
186 rdf:type schema:DefinedTerm
187 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
188 schema:name Clinical Sciences
189 rdf:type schema:DefinedTerm
190 sg:journal.1007212 schema:issn 0009-921X
191 1528-1132
192 schema:name Clinical Orthopaedics and Related Research®
193 rdf:type schema:Periodical
194 sg:person.01103301641.41 schema:affiliation https://www.grid.ac/institutes/grid.265008.9
195 schema:familyName Tan
196 schema:givenName Timothy L.
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103301641.41
198 rdf:type schema:Person
199 sg:person.01231726624.06 schema:affiliation https://www.grid.ac/institutes/grid.418446.b
200 schema:familyName Springer
201 schema:givenName Bryan D.
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231726624.06
203 rdf:type schema:Person
204 sg:person.014077443323.12 schema:affiliation https://www.grid.ac/institutes/grid.418446.b
205 schema:familyName Ruder
206 schema:givenName John A.
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014077443323.12
208 rdf:type schema:Person
209 sg:person.0720501031.10 schema:affiliation https://www.grid.ac/institutes/grid.265008.9
210 schema:familyName Chen
211 schema:givenName Antonia F.
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720501031.10
213 rdf:type schema:Person
214 sg:pub.10.1007/s11999-012-2255-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024095772
215 https://doi.org/10.1007/s11999-012-2255-1
216 rdf:type schema:CreativeWork
217 https://app.dimensions.ai/details/publication/pub.1078990362 schema:CreativeWork
218 https://doi.org/10.1001/archinte.162.7.822 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049908466
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1002/jor.22549 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002096357
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1007/s11999-012-2255-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024095772
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1016/0021-9681(87)90171-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020988115
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1016/j.amjmed.2005.10.052 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050626598
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1016/j.amjsurg.2005.01.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042842159
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1016/j.arth.2010.01.105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031521144
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1016/j.arth.2011.03.044 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011529868
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/j.arth.2012.03.040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025869441
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/s1081-1206(10)62466-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030993384
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1067/mtc.2002.119698 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028764631
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1086/605593 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012385427
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1111/j.1398-9995.1994.tb00809.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1051534928
243 rdf:type schema:CreativeWork
244 https://doi.org/10.2106/jbjs.m.00663 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068903536
245 rdf:type schema:CreativeWork
246 https://www.grid.ac/institutes/grid.265008.9 schema:alternateName Thomas Jefferson University
247 schema:name Rothman Institute at Thomas Jefferson University, Philadelphia, PA, USA
248 rdf:type schema:Organization
249 https://www.grid.ac/institutes/grid.418446.b schema:alternateName OrthoCarolina
250 schema:name OrthoCarolina, Charlotte, NC, USA
251 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...